A carregar...
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
In recent years, there has been a paradigm shift in the treatment of multiple sclerosis (MS) owing to the approval of a number of new drugs with very distinct mechanisms of action. All approved disease-modifying drugs primarily work directly on the immune system. However, the identification of an ‘o...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444778/ https://ncbi.nlm.nih.gov/pubmed/30967901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419836571 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|